Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

URGN holding history

UroGen Pharma Ltd. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

URGN overviewAll 13F holders of URGNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of URGN by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−688−100.0%Sold outHolders
Q1 2026688$12.4K<0.1%00.0%UnchangedHolders
Q4 2025688$16.1K<0.1%00.0%UnchangedHolders
Q3 2025688$13.7K<0.1%+688NewHolders
Q2 20250$00.0%−1,340−100.0%Sold outHolders
Q1 20251,340$14.8K<0.1%+1,314+5,053.8%AddedHolders
Q4 202426$277<0.1%00.0%UnchangedHolders
Q3 202426$331<0.1%00.0%UnchangedHolders
Q2 202426$437<0.1%00.0%UnchangedHolders
Q1 202426$390<0.1%−30−53.6%ReducedHolders
Q4 202356$840<0.1%00.0%UnchangedHolders
Q3 202356$785<0.1%00.0%UnchangedHolders
Q2 202356$580<0.1%00.0%UnchangedHolders
Q1 202356$518<0.1%−41−42.3%ReducedHolders
Q4 202297$860<0.1%00.0%UnchangedHolders
Q3 202297$1.00K<0.1%−104−51.7%ReducedHolders
Q2 2022201$2.00K<0.1%−154−43.4%ReducedHolders
Q1 2022355$3.00K<0.1%+355NewHolders
Q4 20210$00.0%−1,065−100.0%Sold outHolders
Q3 20211,065$18.0K<0.1%+1,020+2,266.7%AddedHolders
Q2 202145$1.00K<0.1%−16−26.2%ReducedHolders
Q1 202161$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.